Companies / Apellis Pharmaceuticals, Inc. / Activity

Activity — Apellis Pharmaceuticals, Inc.

60 moves.

Top impact Insider · CEO moves Insider · biggest buys Insider · biggest sells Institution · biggest moves Institution · new positions

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Jan 22, 2026	Francois Cedric CEO	Sell	Common Stock	$591.8K	-27K -8.68%	286,045 0.22% of shares	medium
Jan 13, 2026	Francois Cedric CEO	Sell	Common Stock	$226.0K	-10K -3.07%	321,419 0.25% of shares	medium
Jan 22, 2026	Sullivan Timothy Eugene Executive	Sell	Common Stock	$223.9K	-10K -9.87%	93,901 0.07% of shares	medium
Jan 22, 2026	Watson David O. Executive	Sell	Common Stock	$170.5K	-8K -8.13%	88,531 0.07% of shares	medium
Jan 22, 2026	Nicholson Nur Executive	Sell	Common Stock	$168.1K	-8K -9.80%	71,118 0.06% of shares	medium
Jan 20, 2026	Francois Cedric CEO	Sell	Common Stock	$161.9K	-8K -2.55%	313,237 0.24% of shares	medium
Jan 22, 2026	Deschatelets Pascal Executive	Sell	Common Stock	$129.0K	-6K -0.51%	1,151,382 0.90% of shares	medium
Jan 13, 2026	Watson David O. Executive	Sell	Common Stock	$128.2K	-6K -5.52%	98,838 0.08% of shares	medium
Jan 13, 2026	Sullivan Timothy Eugene Executive	Sell	Common Stock	$85.6K	-4K -3.48%	107,080 0.08% of shares	low
Jan 5, 2026	Baumal Caroline Executive	Sell	Common Stock	$77.1K	-3K -3.21%	91,206 0.07% of shares	low
Jan 22, 2026	DeLong Mark Jeffrey Executive	Sell	Common Stock	$73.4K	-3K -4.12%	78,353 0.06% of shares	low
Jan 22, 2026	Baumal Caroline Executive	Sell	Common Stock	$60.9K	-3K -3.13%	86,527 0.07% of shares	low
Jan 13, 2026	Nicholson Nur Executive	Sell	Common Stock	$58.1K	-3K -3.13%	81,046 0.06% of shares	low
Jan 20, 2026	Sullivan Timothy Eugene Executive	Sell	Common Stock	$57.2K	-3K -2.70%	104,188 0.08% of shares	low
Jan 13, 2026	Deschatelets Pascal Executive	Sell	Common Stock	$50.5K	-2K -0.20%	1,158,219 0.90% of shares	low
Jan 20, 2026	Watson David O. Executive	Sell	Common Stock	$49.0K	-2K -2.50%	96,363 0.08% of shares	low
Jan 22, 2026	Chopas James George Executive	Sell	Common Stock	$44.9K	-2K -3.98%	49,805 0.04% of shares	low
Jan 20, 2026	Nicholson Nur Executive	Sell	Common Stock	$43.6K	-2K -2.72%	78,843 0.06% of shares	low
Jan 13, 2026	DeLong Mark Jeffrey Executive	Sell	Common Stock	$39.5K	-2K -2.10%	83,058 0.06% of shares	low
Jan 20, 2026	Baumal Caroline Executive	Sell	Common Stock	$37.3K	-2K -2.06%	89,324 0.07% of shares	low
Feb 3, 2026	Francois Cedric CEO	Exercise	Common Stock	$33.2K	+9K +1.83%	490,837 0.38% of shares	low
Jan 20, 2026	DeLong Mark Jeffrey Executive	Sell	Common Stock	$26.4K	-1K -1.61%	81,724 0.06% of shares	low
Jan 13, 2026	Chopas James George Executive	Sell	Common Stock	$19.4K	-873 -1.63%	52,595 0.04% of shares	low
Jan 20, 2026	Deschatelets Pascal Executive	Sell	Common Stock	$18.0K	-909 -0.08%	1,157,310 0.90% of shares	low
Jan 20, 2026	Chopas James George Executive	Sell	Common Stock	$14.4K	-726 -1.38%	51,869 0.04% of shares	low
Jan 7, 2026	Watson David O. Executive	Exercise	Common Stock	$13.3K	+888 +0.86%	104,618 0.08% of shares	low
Feb 11, 2026	DeLong Mark Jeffrey Executive	Sell	Common Stock	$8.2K	-368 -0.32%	114,591 0.09% of shares	low
Jan 28, 2026	Chopas James George Executive	Grant	Common Stock	$0	+16K +32.43%	65,955 0.05% of shares	low
Jan 28, 2026	Nicholson Nur Executive	Grant	Common Stock	$0	+45K +63.58%	116,338 0.09% of shares	low
Jan 1, 2026	Fonteyne Paul R. Director	Grant	Common Stock	$0	+8K +35.06%	30,666 0.02% of shares	low
Jan 1, 2026	Dunlop A. Sinclair Director	Grant	Common Stock	$0	+8K +5.18%	161,567 0.13% of shares	low
Jan 1, 2026	O'Brien Stephanie Monaghan Director	Grant	Common Stock	$0	+8K +44.96%	25,666 0.02% of shares	low
Jan 28, 2026	Sullivan Timothy Eugene Executive	Grant	Common Stock	$0	+58K +61.92%	152,041 0.12% of shares	low
Mar 11, 2026	Francois Cedric CEO	Gift	Common Stock	$0	+65K +21.07%	372,815 0.29% of shares	low
Mar 11, 2026	Francois Cedric CEO	Gift	Common Stock	$0	-65K -13.22%	425,968 0.33% of shares	low
Jan 28, 2026	Francois Cedric CEO	Grant	Common Stock	$0	+196K +68.50%	481,997 0.38% of shares	low
Jan 28, 2026	Deschatelets Pascal Executive	Grant	Common Stock	$0	+26K +2.24%	1,177,222 0.92% of shares	low
Jan 28, 2026	Watson David O. Executive	Grant	Common Stock	$0	+56K +63.24%	144,517 0.11% of shares	low
Jan 1, 2026	Chan Gerald Director	Grant	Common Stock	$0	+8K +44.96%	25,666 0.02% of shares	low
Jan 1, 2026	Machiels Alec Director	Grant	Common Stock	$0	+8K +2.11%	384,989 0.30% of shares	low
Feb 27, 2026	Dolsten Mikael Director	Grant	Common Stock	$0	+14K	14,312 0.01% of shares	low
Jan 28, 2026	Boucher Kelley Executive	Grant	Common Stock	$0	+30K +30.87%	127,804 0.10% of shares	low
Jan 28, 2026	DeLong Mark Jeffrey Executive	Grant	Common Stock	$0	+37K +46.72%	114,959 0.09% of shares	low
Jan 28, 2026	Meltzer Leslie Executive	Grant	Common Stock	$0	+45K +73.17%	107,024 0.08% of shares	low
Jan 1, 2026	Walbert Keli Director	Grant	Common Stock	$0	+8K +87.58%	17,051 0.01% of shares	low
Jan 1, 2026	Wheeler Craig a Director	Grant	Common Stock	$0	+8K +48.30%	24,444 0.02% of shares	low
May 14, 2026	Wheeler Craig a Director	Other	Stock Option (right to buy)	—	-15K -100.00%	0 0.00% of shares	low
May 14, 2026	Wheeler Craig a Director	Other	Stock Option (right to buy)	—	-28K -100.00%	0 0.00% of shares	low
May 14, 2026	Wheeler Craig a Director	Other	Common Stock	—	-8K -100.00%	0 0.00% of shares	low
May 14, 2026	Wheeler Craig a Director	Other	Common Stock	—	-15K -100.00%	0 0.00% of shares	low